Kestra Medical Technologi...

NASDAQ: KMTS · Real-Time Price · USD
16.09
0.13 (0.81%)
At close: Aug 15, 2025, 3:59 PM
16.05
-0.25%
After-hours: Aug 15, 2025, 04:10 PM EDT

Kestra Medical Common Stock Income Statement

Financials in USD. Fiscal year is May - April.
Fiscal Year FY 2024 FY 2023 FY 2022
Period Ending Apr 30, 2025 Apr 30, 2024 Apr 30, 2023
Revenue
59.81M 27.81M 7.63M
Cost of Revenue
35.6M 27.45M 18.28M
Gross Profit
24.21M 362K -10.65M
Operating Income
-106.38M -85.06M -80.42M
Interest Income
3.2M n/a n/a
Pretax Income
-113.68M -94.1M -84.22M
Net Income
-113.81M -94.12M -84.24M
Selling & General & Admin
114.94M 69.94M 54.01M
Research & Development
15.65M 15.49M 15.76M
Other Expenses
n/a n/a n/a
Operating Expenses
130.59M 85.42M 69.77M
Interest Expense
7.73M 6.23M 5.63M
Selling & Marketing Expenses
n/a 40.68M 34.92M
Cost & Expenses
166.19M 112.88M 88.05M
Income Tax Expense
135K 24K 15K
Shares Outstanding (Basic)
49.53M 49.53M 49.53M
Shares Outstanding (Diluted)
49.53M 49.53M 49.53M
EPS (Basic)
-5.13 -2.04 -1.75
EPS (Diluted)
-5.13 -2.04 -1.75
EBITDA
-97.98M -76.31M -73.74M
EBIT
-105.94M -87.87M -78.59M
Depreciation & Amortization
7.97M 11.56M 4.86M